StonvexLoading…
StonvexStonvexStonvexCore line items from PTC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $2.74B | $2.30B | $2.10B | $1.93B |
Operating Income | $982.38M | $588.06M | $458.47M | $447.36M |
Net Income | $734.00M | $376.33M | $245.54M | $313.08M |
EPS (Diluted) | $6.08 | $3.12 | $2.06 | $2.65 |
Total Assets | $6.62B | $6.38B | $6.29B | $4.69B |
Total Liabilities | $2.79B | $3.17B | $3.61B | $2.39B |
Cash & Equivalents | $184.41M | $265.81M | $288.10M | $272.18M |
Free Cash Flow OCF − CapEx | $856.69M | $735.61M | $587.05M | $415.83M |
Shares Outstanding | 119.54M | 120.16M | 118.85M | 117.47M |